"Lung cancers" trang 1 - tải miễn phí từ tailieunhanh
Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung

Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung
10    66    1
Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers

Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers
10    5    1
High frequency of epidermal growth factor receptor mutations in non - small cell lung cancers in Vietnam

High frequency of epidermal growth factor receptor mutations in non - small cell lung cancers in Vietnam
12    72    0
NQO1 protein expression predicts poor prognosis of non-small cell lung cancers

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
9    43    1
NDRG1 downregulates ATF3 and inhibits cisplatininduced cytotoxicity in lung cancer A549 cells

NDRG1 downregulates ATF3 and inhibits cisplatininduced cytotoxicity in lung cancer A549 cells
6    69    0
Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer
12    38    1
Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelialmesenchymal transition signature and longer survival in squamous cell lung carcinoma

Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelialmesenchymal transition signature and longer survival in squamous cell lung carcinoma
10    51    1
A case of synchronous bilateral lung cancers: EML4-ALK positive adenocarcinoma in the right lung and adenocarcinoma in situ (the former bronchioloalveolar carcinoma) in the left lung

A case of synchronous bilateral lung cancers: EML4-ALK positive adenocarcinoma in the right lung and adenocarcinoma in situ (the former bronchioloalveolar carcinoma) in the left lung
4    32    1
The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer

The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer
10    60    0
Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility

Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility
16    67    1
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation
5    36    1
MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1
11    38    1
Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology

Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology
8    41    1
Comparative analysis of overall survival in non-small cell lung cancer patients with and without different organ metastases

Comparative analysis of overall survival in non-small cell lung cancer patients with and without different organ metastases
6    11    1
Efficacy and safety of fuzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: A multi-center, single-arm prospective phase II clinical study (STAMP study)

Efficacy and safety of fuzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: A multi-center, single-arm prospective phase II clinical study (STAMP study)
11    1    1
Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting

Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting
11    5    1
Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid

Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid
9    50    1
Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies – results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers

Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies – results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers
11    46    1
Cancer incidence in the population of Thua Thien Hue Province, vietnam, 2001-2009

Cancer incidence in the population of Thua Thien Hue Province, vietnam, 2001-2009
11    101    0
Claudin-3 inhibits lung squamous cell carcinoma cell epithelial-mesenchymal transition and invasion via suppression of the Wnt/β-catenin signaling pathway

Claudin-3 inhibits lung squamous cell carcinoma cell epithelial-mesenchymal transition and invasion via suppression of the Wnt/β-catenin signaling pathway
13    56    0